LUNG Pulmonx Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$1,83
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,1352-Wochen-Tief
$2,8952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$79M
P/E (TTM)
-1.6
EPS (TTM)
$-1.16
Umsatz (TTM)
$87M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$3
P/E
-1.6
ROE
-88.9%
Nettogewinnmarge
-55.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
LUNG Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.83
Marktkapitalisierung (MRQ)
$79M
P/E (TTM)
-1.6
EPS (TTM)
$-1.16
Umsatz (TTM)
$87M
ROE (TTM)
-88.9%
Verschuldungsgrad (MRQ)
1.0
52W-Spanne
$1–$3
LUNG Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$90M2018-12-31 → 2025-12-31
EPS$-1.332020-12-31 → 2025-12-31
Freier Cashflow$-33M2020-12-31 → 2025-12-31
Nettogewinnmarge-55.0%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | LUNG | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.65-Jahres-Durchschnitt ≈-8.7 | ≈-8.7 | · | · | |
| P/S (TTM) | 0.95-Jahres-Durchschnitt ≈8.4 | ≈8.4 | 3.9 | Unterbewertet | |
| K/B (MRQ) | 2.05-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 3.5 | Unterbewertet | |
| EV / EBITDA | -0.85-Jahres-Durchschnitt ≈-4.1 | ≈-4.1 | · | · | |
| Kurs / FCF (TTM) | -2.65-Jahres-Durchschnitt ≈-11.4 | ≈-11.4 | · | · | |
| Kurs / Cashflow (TTM) | -2.65-Jahres-Durchschnitt ≈-12.0 | ≈-12.0 | · | · | |
| EV / Revenue (EV / Umsatz) | 0.55-Jahres-Durchschnitt ≈3.3 | ≈3.3 | · | · | |
| EV / FCF | -1.45-Jahres-Durchschnitt ≈-6.9 | ≈-6.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.55-Jahres-Durchschnitt ≈3.5 | ≈3.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | LUNG | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 77.1%5-Jahres-Durchschnitt ≈74.0% | ≈74.0% | 50.7% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -53.0%5-Jahres-Durchschnitt ≈-85.1% | ≈-85.1% | -39.8% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | -59.3%5-Jahres-Durchschnitt ≈-85.1% | ≈-85.1% | -39.8% | Im Einklang | |
| Vorgewinnmarge (TTM) | -54.3%5-Jahres-Durchschnitt ≈-84.5% | ≈-84.5% | -43.7% | Im Einklang | |
| Nettogewinnmarge (TTM) | -55.0%5-Jahres-Durchschnitt ≈-85.2% | ≈-85.2% | -44.3% | Im Einklang | |
| ROA (TTM) | -36.7%5-Jahres-Durchschnitt ≈-30.0% | ≈-30.0% | -56.0% | Spitzenklasse | |
| ROE (TTM) | -88.9%5-Jahres-Durchschnitt ≈-52.4% | ≈-52.4% | -5.7% | Schwach | |
| ROIC | -59.5%5-Jahres-Durchschnitt ≈-42.0% | ≈-42.0% | -75.0% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | LUNG | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 1.05-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.5 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 4.35-Jahres-Durchschnitt ≈7.6 | ≈7.6 | 3.2 | Starke Liquidität | |
| Quick Ratio | 4.15-Jahres-Durchschnitt ≈5.3 | ≈5.3 | 3.0 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 1.05-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.5 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | LUNG | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 8.0%5-Jahres-Durchschnitt ≈23.3% | ≈23.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 19.0%5-Jahres-Durchschnitt ≈22.4% | ≈22.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 22.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | LUNG | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.5 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.45-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.7 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 7.25-Jahres-Durchschnitt ≈7.3 | ≈7.3 | 7.8 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$305.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
13.4%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 28, 2026 | $-0.24 | $-0.29 | 16.0% |
| 31. März 2026 | $-0.33 | $-0.33 | 0.96% | |
| 31. Dezember 2025 | $-0.25 | $-0.40 | 37.5% | |
| 30. September 2025 | $-0.34 | $-0.43 | 20.3% | |
| 30. Juni 2025 | $-0.38 | $-0.38 | 0.21% | |
| 31. März 2025 | $-0.36 | $-0.38 | 5.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $90M | $84M | $69M | $54M | $48M | $33M | $33M | $20M | |
| Cost of Revenue | $23M | $22M | $18M | $14M | $13M | $12M | $10M | $8M | |
| Gross Profit | $67M | $62M | $51M | $40M | $36M | $21M | $22M | $12M | |
| R&D Expense | $19M | $18M | $18M | $15M | $13M | $7M | $6M | $7M | |
| SG&A Expense | $101M | $102M | $95M | $83M | $70M | $46M | $34M | $20M | |
| Operating Expenses | $121M | $120M | $113M | $99M | $83M | $54M | $40M | $27M | |
| Operating Income | $-54M | $-58M | $-62M | $-59M | $-47M | $-32M | $-18M | $-15M | |
| Interest Expense | · | · | $3M | $1M | $829.0K | $3M | $2M | $3M | |
| Interest Income | $3M | $5M | $6M | $2M | $400.0K | $213.0K | $432.0K | $21.0K | |
| Other Non-op | $790.0K | $256.0K | $-673.0K | $-396.0K | $-585.0K | $3M | $-617.0K | $-916.0K | |
| Pretax Income | $-53M | $-56M | $-60M | $-59M | $-48M | $-32M | $-20M | $-18M | |
| Income Tax | $626.0K | $500.0K | $571.0K | $353.0K | $343.0K | $213.0K | $363.0K | $12.0K | |
| Net Income | $-54M | $-56M | $-61M | $-59M | $-49M | $-32M | $-21M | $-18M | |
| EPS (Basic) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-3.16 | · | · | |
| EPS (Diluted) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-3.16 | · | · | |
| Shares (Basic) | 40,685,934 | 39,111,073 | 37,974,567 | 37,096,541 | 36,129,409 | 10,184,841 | · | · | |
| Shares (Diluted) | 40,685,934 | 39,111,073 | 37,974,567 | 37,096,541 | 36,129,409 | 10,184,841 | · | · | |
| EBITDA | $-54M | $-58M | $-62M | $-59M | $-47M | $-32M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $71M | $84M | $102M | $148M | $232M | $15M | $4M | |
| Receivables | $12M | $13M | $12M | $9M | $7M | $4M | $6M | · | |
| Inventory | $16M | $17M | $17M | $15M | $16M | $11M | $6M | · | |
| Prepaid Expense | $4M | $4M | $4M | $4M | $5M | $3M | $2M | · | |
| Other Current Assets | $491.0K | $1M | $504.0K | $290.0K | $347.0K | $377.0K | $766.0K | · | |
| Current Assets | $102M | $136M | $150M | $169M | $208M | $250M | $41M | · | |
| PP&E (Net) | $2M | $3M | $4M | $5M | $5M | $1M | $902.0K | · | |
| PP&E (Gross) | $9M | $9M | $9M | $8M | $7M | $3M | $2M | · | |
| Accum. Depreciation | $7M | $6M | $5M | $4M | $2M | $2M | $1M | · | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | |
| Intangibles | · | $0 | $31.0K | $154.0K | $277.0K | $400.0K | $524.0K | · | |
| Other Non-current Assets | $1M | $1M | $591.0K | $529.0K | $731.0K | $536.0K | $579.0K | · | |
| Total Assets | $129M | $163M | $178M | $194M | $235M | $264M | $54M | · | |
| Accounts Payable | $4M | $4M | $1M | $2M | $2M | $1M | $3M | · | |
| Accrued Liabilities | $15M | $16M | $16M | $13M | $13M | $9M | $9M | · | |
| Short-term Debt | $106.0K | $3M | $2M | $90.0K | $91.0K | · | · | · | |
| Current Liabilities | $20M | $24M | $23M | $18M | $18M | $13M | $14M | · | |
| Capital Leases | $18M | $19M | $1M | $4M | $7M | $8M | $6M | · | |
| Deferred Tax | $69.0K | $87.0K | $114.0K | $94.0K | $37.0K | $62.0K | $43.0K | · | |
| Other Non-current Liabilities | · | · | · | · | $179.0K | · | · | · | |
| Total Liabilities | $75M | $77M | $59M | $40M | $42M | $38M | $36M | · | |
| Long-term Debt | $37M | $37M | $37M | $17M | $17M | $17M | · | · | |
| Total Debt | $37M | $37M | $37M | · | · | · | · | · | |
| Common Stock | $42.0K | $40.0K | $39.0K | $38.0K | $37.0K | $36.0K | $2.0K | · | |
| Retained Earnings | $-522M | $-468M | $-411M | $-350M | $-291M | $-243M | $-211M | · | |
| AOCI | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | |
| Stockholders' Equity | $54M | $86M | $118M | $154M | $193M | $226M | $-187M | $-167M | |
| Liabilities + Equity | $129M | $163M | $178M | $194M | $235M | $264M | $54M | · | |
| Shares Outstanding | 41,673,648 | 39,785,969 | 38,516,383 | 37,555,565 | 36,931,762 | 35,693,753 | 2,100,203 | 1,719,446 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $21M | $23M | $22M | $16M | $11M | $3M | $364.0K | $366.0K | |
| Deferred Tax | $-19.0K | $-24.0K | $26.0K | $55.0K | $-24.0K | $19.0K | $-5.0K | $-197.0K | |
| Amort. of Intangibles | · | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-32M | $-32M | $-38M | $-45M | $-41M | $-31M | $-21M | $-18M | |
| CapEx | $452.0K | $1M | $807.0K | $1M | $4M | $911.0K | $720.0K | $316.0K | |
| Investing Cash Flow | $30M | $17M | $-2M | $-4M | $-46M | $13M | $-14M | $200.0K | |
| Debt Issued | · | $0 | $20M | $0 | · | · | · | · | |
| Net Debt Issued | · | $0 | $20M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $27.0K | $26.0K | $21.0K | $12.0K | $0 | |
| Net Stock Activity | · | · | $0 | $-27.0K | $-26.0K | $-21.0K | · | · | |
| Financing Cash Flow | $833.0K | $1M | $21M | $2M | $4M | $235M | $46M | $12M | |
| Net Change in Cash | $-1M | $-13M | $-18M | $-47M | $-83M | $217M | $11M | $-6M | |
| Taxes Paid | $468.0K | $556.0K | $500.0K | $398.0K | $322.0K | $259.0K | $196.0K | $226.0K | |
| Free Cash Flow | $-33M | $-33M | $-38M | $-46M | $-45M | $-32M | · | · | |
| Levered FCF | · | · | $-42M | $-47M | $-46M | $-35M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.2% | 74.0% | 73.9% | 74.3% | 73.6% | 64.8% | · | · | |
| Operating Margin | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | · | · | |
| Net Margin | -59.7% | -67.3% | -88.6% | -109.8% | -100.5% | -98.5% | · | · | |
| Pretax Margin | -59.0% | -66.7% | -87.8% | -109.1% | -99.8% | -97.8% | · | · | |
| EBITDA Margin | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% | -98.8% | · | · | |
| ROA | -37.0% | -33.1% | -32.8% | -27.5% | -19.5% | -20.3% | · | · | |
| ROE | -87.7% | -62.7% | -49.9% | -37.1% | -24.6% | -334.9% | · | · | |
| ROIC | -59.5% | -47.3% | -40.2% | -38.3% | -24.6% | -14.4% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 5.6 | 6.5 | 9.1 | 11.9 | 20.0 | · | · | |
| Quick Ratio | 4.1 | 3.4 | 4.1 | 6.0 | 8.8 | 18.8 | · | · | |
| Debt / Equity | 0.7 | 0.4 | 0.3 | · | · | · | · | · | |
| LT Debt / Equity | 0.7 | 0.4 | 0.3 | · | · | · | · | · | |
| Interest Coverage | · | · | -19.2 | -55.0 | -57.1 | -10.2 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.2 | · | · | |
| Inventory Turnover | 1.4 | 1.3 | 1.1 | 0.9 | 0.9 | 1.4 | · | · | |
| Receivables Turnover | 7.2 | 6.6 | 6.6 | 7.0 | 9.0 | 6.7 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.30 | $2.16 | $3.07 | $4.10 | $5.23 | $6.34 | · | · | |
| Revenue / Share | $2.22 | $2.14 | $1.81 | $1.45 | $1.34 | · | · | · | |
| Cash Flow / Share | $-0.80 | $-0.81 | $-0.99 | $-1.22 | $-1.15 | · | · | · | |
| Cash / Share | $1.67 | $1.78 | $2.17 | $2.71 | $4.02 | $6.49 | · | · | |
| EPS (TTM) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 | $-3.16 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.0% | 22.0% | 28.0% | 10.8% | 47.9% | · | · | · | |
| Revenue CAGR 3Y | 19.0% | 20.1% | 28.0% | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.6% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $90M | $84M | $69M | $54M | $48M | $33M | · | · | |
| Net Income TTM | $-54M | $-56M | $-61M | $-59M | $-49M | $-32M | · | · | |
| Market Cap | $92M | $270M | $491M | $317M | $1.18B | $2.46B | · | · | |
| Enterprise Value | $59M | $236M | $445M | · | · | · | · | · | |
| P/E | -1.7 | -4.7 | -8.0 | -5.3 | -23.8 | -21.8 | · | · | |
| P/S | 1.0 | 3.2 | 7.2 | 5.9 | 24.5 | 75.3 | · | · | |
| P/B | 1.7 | 3.1 | 4.2 | 2.1 | 6.1 | 10.9 | · | · | |
| P / Tangible Book | 1.8 | 3.2 | 4.2 | 2.1 | 6.2 | 11.0 | · | · | |
| P / Cash Flow | -2.8 | -8.6 | -13.1 | -7.0 | -28.6 | -80.4 | · | · | |
| P / FCF | -2.8 | -8.2 | -12.8 | -6.8 | -26.3 | -78.1 | · | · | |
| EV / EBITDA | -1.1 | -4.1 | -7.2 | · | · | · | · | · | |
| EV / FCF | -1.8 | -7.2 | -11.6 | · | · | · | · | · | |
| EV / Revenue | 0.7 | 2.8 | 6.5 | · | · | · | · | · | |
| Earnings Yield | -60.2% | -21.2% | -12.6% | -18.9% | -4.2% | -4.6% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $21M | $23M | $22M | $24M | $23M | $24M | $20M | $21M | $19M | $18M | $17M | $15M | $15M | $14M | $14M | |
| Cost of Revenue | $5M | $5M | $5M | $5M | $7M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $4M | |
| Gross Profit | $18M | $16M | $18M | $16M | $17M | $16M | $18M | $15M | $15M | $14M | $13M | $13M | $11M | $11M | $10M | $10M | |
| R&D Expense | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $6M | $4M | $4M | $6M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $22M | $24M | $23M | $26M | $27M | $26M | $27M | $25M | $25M | $24M | $24M | $23M | $23M | $22M | $20M | $21M | |
| Operating Expenses | $27M | $29M | $27M | $30M | $32M | $31M | $31M | $29M | $31M | $29M | $28M | $29M | $27M | $26M | $24M | $25M | |
| Operating Income | $-9M | $-13M | $-10M | $-14M | $-15M | $-15M | $-13M | $-14M | $-16M | $-15M | $-15M | $-16M | $-16M | $-15M | $-14M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $883.0K | $893.0K | $864.0K | $571.0K | $359.0K | $286.0K | $223.0K | |
| Interest Income | $329.0K | $350.0K | $453.0K | $611.0K | $723.0K | $864.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $748.0K | $477.0K | $199.0K | |
| Other Non-op | $-1.0K | $77.0K | $-19.0K | $758.0K | $-116.0K | $167.0K | $77.0K | $-201.0K | $-35.0K | $415.0K | $-262.0K | $-162.0K | $108.0K | $201.0K | $-432.0K | $-165.0K | |
| Pretax Income | $-10M | $-14M | $-10M | $-14M | $-15M | $-14M | $-13M | $-14M | $-15M | $-14M | $-15M | $-16M | $-16M | $-14M | $-14M | $-15M | |
| Income Tax | $133.0K | $149.0K | $186.0K | $128.0K | $177.0K | $135.0K | $38.0K | $192.0K | $84.0K | $186.0K | $59.0K | $140.0K | $124.0K | $246.0K | $0 | $40.0K | |
| Net Income | $-10M | $-14M | $-10M | $-14M | $-15M | $-14M | $-13M | $-14M | $-15M | $-14M | $-15M | $-16M | $-16M | $-14M | $-14M | $-15M | |
| EPS (Basic) | $-0.24 | $-0.33 | $-0.25 | $-0.34 | $-0.38 | $-0.36 | $-0.33 | $-0.36 | $-0.39 | $-0.36 | $-0.39 | $-0.43 | $-0.42 | $-0.38 | $-0.38 | $-0.40 | |
| EPS (Diluted) | $-0.24 | $-0.33 | $-0.25 | $-0.34 | $-0.38 | $-0.36 | $-0.33 | $-0.36 | $-0.39 | $-0.36 | $-0.39 | $-0.43 | $-0.42 | $-0.38 | $-0.38 | $-0.40 | |
| Shares (Basic) | 42,468,762 | 41,897,669 | · | 40,936,896 | 40,429,655 | 39,954,658 | · | 39,276,447 | 38,943,066 | 38,636,029 | 38,119,824 | 37,818,256 | 37,572,382 | · | 37,190,352 | 37,003,443 | |
| Shares (Diluted) | 42,468,762 | 41,897,669 | · | 40,936,896 | 40,429,655 | 39,954,658 | · | 39,276,447 | 38,943,066 | 38,636,029 | 38,119,824 | 37,818,256 | 37,572,382 | · | 37,190,352 | 37,003,443 | |
| EBITDA | $-9M | $-13M | · | $-14M | $-15M | $-15M | · | $-14M | $-16M | $-15M | $-15M | $-16M | $-16M | · | $-14M | $-14M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $62M | $70M | $77M | $75M | $75M | $71M | $63M | $63M | $70M | $95M | $102M | $110M | $102M | $112M | $122M | |
| Receivables | $12M | $11M | $12M | $14M | $16M | $14M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | |
| Inventory | $16M | $16M | $16M | $16M | $16M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | $15M | $16M | $19M | |
| Prepaid Expense | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | |
| Other Current Assets | $32.0K | $44.0K | $491.0K | $129.0K | $124.0K | $274.0K | $1M | $198.0K | $177.0K | $77.0K | $193.0K | $118.0K | $147.0K | $290.0K | $183.0K | $0 | |
| Current Assets | $88M | $93M | $102M | $111M | $120M | $124M | $136M | $141M | $146M | $148M | $147M | $164M | $181M | $169M | $183M | $193M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | |
| PP&E (Gross) | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | · | · | · | · | · | · | · | $0 | $0 | $0 | $62.0K | $92.0K | $123.0K | $154.0K | $185.0K | $216.0K | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $654.0K | $515.0K | $577.0K | $415.0K | $448.0K | $465.0K | $529.0K | $687.0K | $796.0K | |
| Total Assets | $115M | $120M | $129M | $138M | $147M | $151M | $163M | $167M | $173M | $165M | $185M | $193M | $201M | $194M | $202M | $213M | |
| Accounts Payable | $5M | $3M | $4M | $6M | $7M | $4M | $4M | $5M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $3M | |
| Accrued Liabilities | $14M | $14M | $15M | $15M | $14M | $12M | $16M | $13M | $12M | $10M | $14M | $14M | $11M | $13M | $11M | $12M | |
| Short-term Debt | $103.0K | $104.0K | $106.0K | $105.0K | $104.0K | $8M | $3M | $99.0K | $93.0K | $5M | $91.0K | $93.0K | $91.0K | $90.0K | $5M | $3M | |
| Current Liabilities | $20M | $19M | $20M | $23M | $22M | $25M | $24M | $18M | $16M | $21M | $20M | $20M | $17M | $18M | $22M | $20M | |
| Capital Leases | $17M | $18M | $18M | $18M | $19M | $19M | $19M | $18M | $18M | $650.0K | $2M | $2M | $3M | $4M | $5M | $5M | |
| Deferred Tax | $62.0K | $72.0K | $69.0K | $47.0K | $41.0K | $79.0K | $87.0K | $129.0K | $118.0K | $140.0K | $97.0K | $94.0K | $71.0K | $94.0K | $51.0K | $47.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $179.0K | |
| Total Liabilities | $76M | $74M | $75M | $78M | $78M | $73M | $77M | $73M | $71M | $54M | $59M | $59M | $57M | $40M | $39M | $41M | |
| Long-term Debt | $38M | $37M | $37M | $37M | $37M | $37M | · | $37M | $37M | $37M | $37M | $37M | $37M | · | $17M | $17M | |
| Total Debt | $38M | $37M | · | $37M | $37M | $37M | · | $37M | $37M | $37M | $37M | $37M | $37M | · | $17M | $17M | |
| Common Stock | $43.0K | $42.0K | $42.0K | $41.0K | $41.0K | $40.0K | $40.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $38.0K | $38.0K | $37.0K | $37.0K | |
| Retained Earnings | $-545M | $-535M | $-522M | $-511M | $-497M | $-482M | $-468M | $-454M | $-440M | $-425M | $-397M | $-382M | $-366M | $-350M | $-336M | $-322M | |
| AOCI | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Stockholders' Equity | $39M | $46M | $54M | $60M | $69M | $78M | $86M | $94M | $101M | $110M | $126M | $134M | $144M | $154M | $163M | $172M | |
| Liabilities + Equity | $115M | $120M | $129M | $138M | $147M | $151M | $163M | $167M | $173M | $165M | $185M | $193M | $201M | $194M | $202M | $213M | |
| Shares Outstanding | 42,948,269 | 42,237,203 | 41,673,648 | 41,246,534 | 40,743,806 | 40,247,480 | 39,785,969 | 39,487,879 | 39,151,861 | 38,812,175 | 38,301,446 | 38,016,671 | 37,730,676 | 37,555,565 | 37,408,028 | 37,266,030 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $4M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $100.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-5M | $-10M | $-7M | $-8M | $-4M | $-13M | $-7M | $-7M | $-6M | $-12M | $-9M | $-8M | $-13M | $-10M | $-11M | $-10M | |
| CapEx | $1.0K | $9.0K | $13.0K | $89.0K | $49.0K | $301.0K | $111.0K | $416.0K | $469.0K | $451.0K | $492.0K | $54.0K | $61.0K | $176.0K | $279.0K | $299.0K | |
| Investing Cash Flow | $-1.0K | $-9.0K | $-13.0K | $9M | $5M | $16M | $14M | $7M | $-835.0K | $-3M | $987.0K | $-813.0K | $574.0K | $-727.0K | $44.0K | $2M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $20M | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | $20M | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $27.0K | $0 | $0 | |
| Financing Cash Flow | $-513.0K | $2M | $55.0K | $181.0K | $-67.0K | $664.0K | $62.0K | $459.0K | $-22.0K | $864.0K | $571.0K | $92.0K | $21M | $67.0K | $906.0K | $131.0K | |
| Net Change in Cash | $-6M | $-8M | $-7M | $1M | $913.0K | $4M | $8M | $-151.0K | $-7M | $-13M | $-7M | $-9M | $9M | $-11M | $-10M | $-7M | |
| Taxes Paid | $207.0K | $76.0K | $104.0K | $150.0K | $105.0K | $109.0K | $95.0K | $185.0K | $106.0K | $170.0K | $162.0K | $114.0K | $92.0K | $61.0K | $109.0K | $199.0K | |
| Free Cash Flow | · | $-10M | · | · | · | $-14M | · | · | · | $-12M | · | · | $-13M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | $-13M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 77.9% | · | 74.7% | 72.1% | 72.5% | · | 73.7% | 73.7% | 74.7% | 73.7% | 74.1% | 72.9% | · | 75.2% | 74.7% | |
| Operating Margin | -39.8% | -62.9% | · | -66.9% | -62.1% | -64.6% | · | -69.3% | -75.2% | -77.1% | -85.9% | -95.6% | -112.8% | · | -103.2% | -103.3% | |
| Net Margin | -44.3% | -66.3% | · | -64.9% | -63.6% | -64.1% | · | -69.4% | -73.7% | -72.9% | -84.3% | -94.2% | -109.1% | · | -105.0% | -105.0% | |
| Pretax Margin | -43.7% | -65.6% | · | -64.3% | -62.8% | -63.5% | · | -68.4% | -73.3% | -71.9% | -84.0% | -93.4% | -108.3% | · | -105.0% | -104.7% | |
| EBITDA Margin | -39.8% | -62.9% | · | -66.9% | -62.1% | -64.6% | · | -69.3% | -75.2% | -77.1% | -85.9% | -95.6% | -112.8% | · | -103.2% | -103.3% | |
| ROA | -7.7% | -10.1% | · | -9.1% | -9.5% | -9.2% | · | -8.0% | -8.4% | -7.5% | -7.7% | -8.0% | -7.5% | · | -6.3% | -6.3% | |
| ROE | -18.6% | -22.1% | · | -18.1% | -17.8% | -15.4% | · | -12.9% | -13.0% | -10.8% | -10.3% | -10.6% | -9.7% | · | -7.7% | -7.7% | |
| ROIC | -12.0% | -15.8% | · | -14.9% | -14.1% | -12.8% | · | -10.9% | -11.3% | -10.0% | -9.3% | -9.7% | -9.1% | · | -7.7% | -7.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 4.9 | · | 4.9 | 5.3 | 5.0 | · | 7.7 | 9.0 | 6.9 | 7.2 | 8.4 | 10.6 | · | 8.4 | 9.4 | |
| Quick Ratio | 3.3 | 3.8 | · | 3.9 | 4.1 | 3.5 | · | 4.1 | 4.6 | 3.8 | 5.1 | 5.7 | 6.9 | · | 5.5 | 6.3 | |
| Debt / Equity | 1.0 | 0.8 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | · | 0.1 | 0.1 | |
| LT Debt / Equity | 1.0 | 0.8 | · | 0.6 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | · | 0.1 | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -16.5 | -17.0 | -19.0 | -28.7 | · | -48.7 | -64.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | |
| Receivables Turnover | 1.6 | 1.7 | · | 1.7 | 1.8 | 1.8 | · | 1.9 | 2.1 | 2.0 | 2.0 | 2.1 | 1.9 | · | 1.9 | 1.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.91 | $1.08 | · | $1.46 | $1.70 | $1.93 | · | $2.38 | $2.58 | $2.85 | $3.28 | $3.52 | $3.81 | · | $4.37 | $4.62 | |
| Revenue / Share | $0.54 | $0.49 | · | $0.53 | $0.59 | $0.56 | · | $0.52 | $0.53 | $0.49 | $0.46 | $0.45 | $0.39 | · | $0.36 | $0.38 | |
| Cash Flow / Share | · | $-0.24 | · | · | · | $-0.33 | · | · | · | $-0.31 | · | · | $-0.34 | · | · | · | |
| Cash / Share | $1.30 | $1.46 | · | $1.86 | $1.85 | $1.85 | · | $1.60 | $1.62 | $1.81 | $2.48 | $2.67 | $2.93 | · | $3.00 | $3.27 | |
| EPS (TTM) | $-1.16 | $-1.30 | · | $-1.41 | $-1.43 | $-1.44 | · | · | · | · | $-1.62 | $-1.61 | $-1.58 | · | $-1.57 | $-1.47 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $87M | $89M | · | $92M | $91M | $87M | · | · | · | · | $65M | $61M | $57M | · | $52M | $52M | |
| Net Income TTM | $-48M | $-53M | · | $-57M | $-57M | $-57M | · | · | · | · | $-61M | $-61M | $-59M | · | $-58M | $-54M | |
| Market Cap | $56M | $54M | · | $67M | $106M | $271M | · | $327M | $248M | $360M | $396M | $498M | $422M | · | $623M | $549M | |
| Enterprise Value | $38M | $30M | · | $27M | $67M | $234M | · | $301M | $222M | $327M | $338M | $434M | $349M | · | $528M | $444M | |
| P/E | -1.1 | -1.0 | · | -1.1 | -1.8 | -4.7 | · | · | · | · | -6.4 | -8.1 | -7.1 | · | -10.6 | -10.0 | |
| P/S | 0.6 | 0.6 | · | 0.7 | 1.2 | 3.1 | · | · | · | · | 6.1 | 8.2 | 7.3 | · | 12.0 | 10.6 | |
| P/B | 1.4 | 1.2 | · | 1.1 | 1.5 | 3.5 | · | 3.5 | 2.5 | 3.3 | 3.1 | 3.7 | 2.9 | · | 3.8 | 3.2 | |
| P / Tangible Book | 1.5 | 1.3 | · | 1.2 | 1.6 | 3.6 | · | 3.6 | 2.5 | 3.3 | 3.2 | 3.8 | 3.0 | · | 3.9 | 3.2 | |
| P / Cash Flow | · | -5.4 | · | · | · | -20.5 | · | · | · | -30.5 | · | · | -33.4 | · | · | · | |
| EV / Revenue | 0.4 | 0.3 | · | 0.3 | 0.7 | 2.7 | · | · | · | · | 5.2 | 7.2 | 6.1 | · | 10.2 | 8.6 | |
| Earnings Yield | -89.2% | -100.8% | · | -87.0% | -55.2% | -21.4% | · | · | · | · | -15.7% | -12.3% | -14.1% | · | -9.4% | -10.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $90M | $84M | $69M | $54M | $48M |
| Bruttogewinnmarge % | 74.2% | 74.0% | 73.9% | 74.3% | 73.6% |
| Betriebsgewinnmarge % | -59.3% | -68.9% | -90.2% | -109.3% | -97.7% |
| Nettoergebnis | $-54M | $-56M | $-61M | $-59M | $-49M |
| Verwässerte EPS | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | 0.4 | 0.3 | · | · |
| Liquiditätsgrad | 5.1 | 5.6 | 6.5 | 9.1 | 11.9 |
| Quick Ratio | 4.1 | 3.4 | 4.1 | 6.0 | 8.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-33M | $-33M | $-38M | $-46M | $-45M |
Institutionelle Eigentümer (13F) 118 Einreicher · $41.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
118
Gehaltener Wert
$41.7M
Neue Positionen
20
Geschlossene Positionen
24
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 20 (-3 vs. Vorquartal) | 24 (+7 vs. Vorquartal) | 39 (0 vs. Vorquartal) | 35 (-2 vs. Vorquartal) | -5.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | $5.996.030 | 4.612.331 | 14,39% | Aktien |
| VANGUARD GROUP INC | $5.614.582 | 2.540.535 | 13,48% | Aktien |
| MORGAN STANLEY | $3.799.797 | 2.922.921 | 9,12% | Aktien |
| Soleus Capital Management, L.P. | $3.624.820 | 2.788.323 | 8,70% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.119.285 | 1.630.219 | 5,09% | Aktien |
| ExodusPoint Capital Management, LP | $1.590.622 | 1.223.555 | 3,82% | Aktien |
| Kent Lake PR LLC | $1.500.374 | 926.157 | 3,60% | Aktien |
| Almitas Capital LLC | $1.383.463 | 1.064.202 | 3,32% | Aktien |
| BlackRock, Inc. | $1.147.238 | 882.490 | 2,75% | Aktien |
| Stonepine Capital Management, LLC | $1.060.067 | 815.436 | 2,54% | Aktien |
| JANE STREET GROUP, LLC | $985.700 | 758.231 | 2,37% | Aktien |
| BRAIDWELL LP | $978.303 | 752.541 | 2,35% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $968.453 | 744.963 | 2,32% | Aktien |
| Parkman Healthcare Partners LLC | $840.533 | 646.564 | 2,02% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $588.714 | 452.684 | 1,41% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $552.643 | 425.110 | 1,33% | Aktien |
| ADAR1 Capital Management, LLC | $525.846 | 404.497 | 1,26% | Aktien |
| DEUTSCHE BANK AG\ | $523.011 | 402.316 | 1,26% | Aktien |
| KOTLER KEVIN | $442.000 | 200.000 | 1,06% | Aktien |
| D. E. Shaw & Co., Inc. | $425.787 | 327.528 | 1,02% | Aktien |
| Jefferies Financial Group Inc. | $370.643 | 285.110 | 0,89% | Aktien |
| CFM WEALTH PARTNERS LLC | $343.251 | 264.039 | 0,82% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $325.664 | 250.511 | 0,78% | Aktien |
| MARSHALL WACE, LLP | $299.959 | 230.738 | 0,72% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $272.423 | 209.556 | 0,65% | Aktien |
| UBS Group AG | $265.269 | 204.053 | 0,64% | Aktien |
| CITADEL ADVISORS LLC | $261.430 | 201.100 | 0,63% | Verkaufsoption |
| Birchview Capital, LP | $260.706 | 200.543 | 0,63% | Aktien |
| Centiva Capital, LP | $260.124 | 200.095 | 0,62% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $260.000 | 200.000 | 0,62% | Aktien |
| HSBC HOLDINGS PLC | $249.092 | 193.846 | 0,60% | Aktien |
| STATE STREET CORP | $248.951 | 191.501 | 0,60% | Aktien |
| Squarepoint Ops LLC | $238.625 | 183.558 | 0,57% | Aktien |
| CITADEL ADVISORS LLC | $186.425 | 143.404 | 0,45% | Aktien |
| GOLDMAN SACHS GROUP INC | $175.946 | 135.343 | 0,42% | Aktien |
| JANE STREET GROUP, LLC | $160.940 | 123.800 | 0,39% | Verkaufsoption |
| XTX Topco Ltd | $153.448 | 118.037 | 0,37% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $143.000 | 110.000 | 0,34% | Aktien |
| BANK OF MONTREAL /CAN/ | $137.745 | 105.958 | 0,33% | Aktien |
| NORTHERN TRUST CORP | $135.355 | 104.119 | 0,32% | Aktien |
| Redhawk Wealth Advisors, Inc. | $129.542 | 99.648 | 0,31% | Aktien |
| ALGERT GLOBAL LLC | $127.832 | 98.332 | 0,31% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $127.243 | 97.791 | 0,31% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $112.548 | 86.575 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $111.020 | 85.400 | 0,27% | Verkaufsoption |
| IEQ CAPITAL, LLC | $89.906 | 69.158 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $83.685 | 64.373 | 0,20% | Aktien |
| Quadrature Capital Ltd | $83.083 | 63.910 | 0,20% | Aktien |
| Engineers Gate Manager LP | $81.366 | 62.589 | 0,20% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $79.732 | 61.332 | 0,19% | Aktien |
Unternehmensinsider 17 Insider · 8 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Glendon E. French III | President and CEO | 1. September 2026 S | 1.137.936 | 0 | 10 | $-292.323 |
| Steven S. Williamson | PRESIDENT AND CEO | 2. September 2025 S | 358.967 | 0 | 0 | $0 |
| Derrick Sung | COO and CFO | 1. Dezember 2025 A | 1.335.319 | 0 | 0 | $0 |
| Mehul Joshi | Chief Financial Officer & PAO | 2. September 2025 S | 208.489 | 0 | 0 | $0 |
| John Mckune | INTERIM CFO | 1. März 2024 A | 76.210 | 0 | 0 | $0 |
| Srikanth Radhakrishnan | Chief Science & Techn. Officer | 1. September 2026 S | 316.994 | 0 | 12 | $-69.508 |
| Geoffrey Beran Rose | Chief Commercial Officer | 1. September 2026 S | 449.832 | 0 | 16 | $-51.144 |
| David Aaron Lehman | General Counsel | 1. September 2026 S | 361.827 | 0 | 16 | $-88.505 |
| Tiffany Sullivan | Direktor | 5. Juni 2026 A | 115.199 | 0 | 0 | $0 |
| Georgia Melenikiotou | Direktor | 5. Juni 2026 A | 139.714 | 0 | 0 | $0 |
| Thomas William Burns | Direktor | 5. Juni 2026 A | 113.399 | 0 | 0 | $0 |
| Florin Daniel P | Direktor | 5. Juni 2026 A | 133.910 | 0 | 1 | $-46.409 |
| Dana G Mead Jr. | Direktor | 5. Juni 2026 A | 139.714 | 0 | 0 | $0 |
| Richard Ferrari | Direktor | 5. Juni 2026 A | 127.024 | 0 | 0 | $0 |
| Alissa Hsu Lynch | Direktor | 1. Juni 2023 A | 24.530 | 0 | 0 | $0 |
| Staffan Lindstrand | Direktor | 5. Oktober 2020 C | 17.004 | 0 | 0 | $0 |
| BOSTON SCIENTIFIC CORP | · | 13. Juli 2021 S | 1.488.106 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
LUNG Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$3.00
+63,9%
3 27,3%
Starker Kauf
5 45,5%
Kauf
3 27,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-10-02Mittelwert-Ziel $3.40 +85,8%
← Unter allen Zielen
Aktueller Preis $1.83
Tief$2.50
Mittelwert$3.40
Hoch$5.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| HYPR | · | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| LNSR | · | -4.1 | 9.2% | · | · | · |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026